PL439409A1 - Fragrance composition to be incorporated into a fragrance diffuser - Google Patents

Fragrance composition to be incorporated into a fragrance diffuser

Info

Publication number
PL439409A1
PL439409A1 PL439409A PL43940921A PL439409A1 PL 439409 A1 PL439409 A1 PL 439409A1 PL 439409 A PL439409 A PL 439409A PL 43940921 A PL43940921 A PL 43940921A PL 439409 A1 PL439409 A1 PL 439409A1
Authority
PL
Poland
Prior art keywords
fragrance
nicotine
composition
diffuser
version
Prior art date
Application number
PL439409A
Other languages
Polish (pl)
Inventor
Łukasz Pranszke
Original Assignee
Pranszke Łukasz I.S.Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pranszke Łukasz I.S.Company filed Critical Pranszke Łukasz I.S.Company
Priority to PL439409A priority Critical patent/PL439409A1/en
Publication of PL439409A1 publication Critical patent/PL439409A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10—Chemical features of tobacco products or tobacco substitutes
    • A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A24B15/167—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L9/00—Disinfection, sterilisation or deodorisation of air
    • A61L9/14—Disinfection, sterilisation or deodorisation of air using sprayed or atomised substances including air-liquid contact processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q13/00—Formulations or additives for perfume preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Addiction (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Przedmiotem zgłoszenia jest kompozycja zapachowa przeznaczona do wprowadzania do dyfuzora zapachu utworzona przez zmieszane ze sobą składniki. Kompozycja ta charakteryzuje się tym, że zawiera: od 40,0% do 45,0% glikolu propylenowego; od 40,0% do 45,0% gliceryny, od 8,0% do 10,0% aromatów, od 0,0% do 0,5% etanolu, nikotynę. Kompozycja w pierwszej swojej wersji zawiera: 0,3% nikotyny. Kompozycja zapachowa w drugiej swojej wersji zawiera 0,6% nikotyny. Kompozycja zapachowa przeznaczona do wprowadzania do dyfuzora zapachu utworzona przez zmieszane ze sobą składniki w trzeciej wersji zawiera: od 40,0% do 43,0% glikolu propylenowego, od 40,0% do 43,0% gliceryny, od 8,0% do 10,0% aromatów, od 0,0% do 0,5% etanol, 1,2% nikotyny. Kompozycja zapachowa przeznaczona do wprowadzania do dyfuzora zapachu utworzona przez zmieszane ze sobą składniki charakteryzuje się tym, że zawiera: od 38,0% do 42,0% glikolu propylenowego, od 38,0% do 42,0% gliceryny, od 8,0% do 10,0% aromatów, od 0,0% do 0,5% etanolu, nikotynę, przy czym w czwartej wersji zawiera 1,8% nikotyny, w piątej wersji zawiera 3,6% nikotyny, a w szóstej wersji zawiera 7,2 % nikotyny.The subject of the application is a fragrance composition intended to be introduced into a fragrance diffuser formed by components mixed together. The composition is characterized in that it comprises: from 40.0% to 45.0% propylene glycol; 40.0% to 45.0% glycerin, 8.0% to 10.0% flavors, 0.0% to 0.5% ethanol, nicotine. The composition in its first version contains: 0.3% nicotine. The fragrance composition in its second version contains 0.6% nicotine. The fragrance composition to be introduced into the fragrance diffuser formed by the mixed components of the third version contains: from 40.0% to 43.0% propylene glycol, from 40.0% to 43.0% glycerin, from 8.0% to 10.0% flavors, 0.0% to 0.5% ethanol, 1.2% nicotine. The fragrance composition intended to be introduced into the fragrance diffuser, formed by the components mixed together, is characterized by the fact that it contains: from 38.0% to 42.0% propylene glycol, from 38.0% to 42.0% glycerin, from 8.0% % to 10.0% flavors, 0.0% to 0.5% ethanol, nicotine, with the fourth version containing 1.8% nicotine, the fifth version containing 3.6% nicotine, and the sixth version containing 7, 2% nicotine.

PL439409A 2021-11-03 2021-11-03 Fragrance composition to be incorporated into a fragrance diffuser PL439409A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL439409A PL439409A1 (en) 2021-11-03 2021-11-03 Fragrance composition to be incorporated into a fragrance diffuser

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL439409A PL439409A1 (en) 2021-11-03 2021-11-03 Fragrance composition to be incorporated into a fragrance diffuser

Publications (1)

Publication Number Publication Date
PL439409A1 true PL439409A1 (en) 2022-05-09

Family

ID=81534693

Family Applications (1)

Application Number Title Priority Date Filing Date
PL439409A PL439409A1 (en) 2021-11-03 2021-11-03 Fragrance composition to be incorporated into a fragrance diffuser

Country Status (1)

Country Link
PL (1) PL439409A1 (en)

Similar Documents

Publication Publication Date Title
NO20060978L (en) Pharmaceutical compositions for the treatment of premature ejaculation by pulmonary inhalation
BRPI0714417B8 (en) method for making an oral care, personal care, cleanser and / or home care composition
EP4454703A3 (en) Pharmaceutical compositions with low amounts of nitrosamine impurities and methods for producing the same
TW200626558A (en) Indazolone derivatives
CY1107906T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING OSTETROL PRODUCTS FOR USE IN CANCER TREATMENT
NO20076053L (en) Pyrazole pyrimidine derivative for the treatment and prevention of liver disease
SA522431498B1 (en) 3,6-diamino-pyridazin-3-yl derivatives, pharmaceutical compositions containing them and their use as cytostatic agents
BR112019002199A2 (en) compound, heating composition, flavoring or fragrance composition, topical composition, consumer product and method for improving, refining or modifying the taste or odor properties of a flavoring or fragrance composition
CR20230531A (en) Anti-tslp antibody compositions and uses thereof
MX2010007745A (en) Rheology modifying admixture.
NO20073762L (en) Visco-supplement composition and methods
UA87841C2 (en) Topical composition containing ambroxol
SG158869A1 (en) A tetracycline metal complex in a solid dosage form
PL434762A1 (en) Binding agent for materials containing cellulose and product containing it
MX2021006190A (en) Non-aluminium antiperspirant compositions.
DE60309200D1 (en) ALIPHATIC COMPOUNDS AS FRAGRANCES WITH MOSCHUS CHARACTER
EA200800299A1 (en) WATER ANESTHESIC COMPOSITIONS CONTAINING PROPHOFOL
AR046213A1 (en) FORM OF PRESENTATION OF SODIUM NAPROXEN
TW200612962A (en) Estriol and estetrol prodrugs
MX2023003147A (en) Polysorbate mixtures having modified fatty acid ester distribution.
GEP20125563B (en) 2-amino-2-phenylalkanol derivatives, preparation method thereof and pharmaceutical compositions containing same
PL431521A1 (en) Composition supporting the mineralization of teeth in the form of a powder tablet
CN309515015S (en) Aromatherapy machine
MX2023013475A (en) Use of new combination of solvents for fragrances.
CN309538049S (en) Multifunctional perfume diffuser